First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial-Reference-Cited by-同舟云学术

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

Published:2011-04 Issue:4 Volume:11 Page:273-283
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference28 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection;Palella;N Engl J Med,1998

2. Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease;Vigouroux;Diabetes Metab,1999

3. Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants;Faye;Pediatr Infect Dis J,2002

4. A trial of three antiretroviral regimens in HIV-1-infected children;Luzuriaga;N Engl J Med,2004

5. Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children;Funk;AIDS,1999

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Associated factors of malnutrition status among children and adolescents living with HIV in Tanzania: Individual-level analysis and marginal effect estimation;International Journal of STD & AIDS;2023-11-01

3. Incidence of switching to second-line antiretroviral therapy and its predictors among children on antiretroviral therapy at general hospitals, Northern Ethiopia: A survival analysis;PLOS ONE;2023-09-08

4. Global variations in pubertal growth spurts in adolescents living with perinatal HIV;AIDS;2023-05-17

5. A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children;American Journal of Epidemiology;2023-03-09